Karimi, Fariba, and Arash Arya. “SGLT2 Inhibitor-Induced Ketonemia and Its Related Metabolic and Anti-Inflammatory Impacts in Adult Patients With Type 2 Diabetes: SGLT2 Inhibitor-Induced Ketonemia in Type 2 Diabetes”. Iranian Journal of Pharmaceutical Sciences, vol. 19, no. 2, Apr. 2023, pp. 176-87, doi:10.22037/ijps.v19i2.42072.